KAŇKOVÁ, Kateřina, Ivana MÁROVÁ and Andrea STEJSKALOVÁ. Relationship between genetic polymorphism of antioxidant enzymes and diabetic complications. In Stress, Signalling and Control. London, Great Britain: Biochemical Society, 2003, p. 59.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Relationship between genetic polymorphism of antioxidant enzymes and diabetic complications
Name in Czech Vztah mezi genetickym polymorfizmem v antioxidacnim systemu a diabetickymi komplikacemi
Authors KAŇKOVÁ, Kateřina (203 Czech Republic, guarantor), Ivana MÁROVÁ (203 Czech Republic) and Andrea STEJSKALOVÁ (203 Czech Republic).
Edition London, Great Britain, Stress, Signalling and Control, p. 59-59, 2003.
Publisher Biochemical Society
Other information
Original language English
Type of outcome Proceedings paper
Field of Study 30202 Endocrinology and metabolism
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/03:00008083
Organization unit Faculty of Medicine
Keywords in English diabetes mellitus; complications; polymorphism; antioxidant
Tags antioxidant, complications, diabetes mellitus, polymorphism
Changed by Changed by: prof. MUDr. Kateřina Kaňková, Ph.D., učo 2524. Changed: 11/2/2005 12:55.
Abstract
Background and Aims: Association of genetic polymorphisms in glyoxalase I (A111E GLYI), paraoxonase (-107C/T, M55L and R192Q PON) and NAD(P)H: quinone oxidoreductase genes (P187S NQO1) with diabetes-associated microvascular dermatoses (DAMD) in patients with type 2 diabetes mellitus and analogical microvascular dermatoses (MD) in non-diabetics was studied. Materials and Methods: A total of 456 subjects was enrolled in the association study comprising four groups of subjects: diabetics with and without DAMD and non-diabetics with and without MD. Results: Significant difference in genotype frequencies of the A111E GLYI between DAMD and non-DAMD group was found; frequency of the E allele was higher in DAMD group (58.8% vs. 55.6%). Moreover, marginally significant association of allele M with DAMD was detected for the M55L PON polymorphism (P=0.062); 67.3% in DAMD vs. 59.6% in non-DAMD group. When both DAMD/MD group pooled together, association of GLYI 111E and PON 55M with cutaneous manifestation was proved irrespective of diabetes (P=0.018 and 0.021, respectively). Frequencies of A111E GLY1 and M55L PON haplotypes were significantly different between DAMD/MD and non- DAMD/MD groups (P=0.016). Conclusions: Polymorphisms in genes encoding antioxidant enzymes could belong to cluster of genetic susceptibility risk factors for diabetic complications.
Abstract (in Czech)
Polymorfizmus v genech kodujicich antioxidacni enzymy nalezi ke skupine genetickych rizikovych faktoru pro diabeticke komplikace.
Links
GP303/02/D127, research and development projectName: Vztah genetické variability antioxidačního systému k pozdním komplikacím diabetu mellitu
Investor: Czech Science Foundation, Relationship between genetic variability of antioxidant system and late complications of diabetes mellitus
MSM 141100002, plan (intention)Name: Molekulární patofyziologie multigenních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Molecular pathophysiology of multigene diseases
PrintDisplayed: 30/4/2024 19:30